Dow Up 0.07% Nasdaq Up 0.61%

Novavax, Inc. (NVAX)

-NasdaqGS
5.44 Up 0.18(3.42%) Nov 26, 4:00PM EST
Prev Close:5.26
Open:5.24
Bid:4.46 x 200
Ask:N/A
1y Target Est:10.07
Beta:1.67
Next Earnings Date:N/A
Day's Range:5.20 - 5.45
52wk Range:3.34 - 6.95
Volume:2,153,613
Avg Vol (3m):3,778,880
Market Cap:1.30B
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NVAXUp 3.42%1.30B
MRKUp 0.69%170.34B
NVSUp 0.55%231.13B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):38.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.32
Quarterly EPS Est (Dec-14) :-0.08
Mean Recommendation*:1.4
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback